Pharmalot… Pharmalittle… We’re Back
2 CommentsBy Ed Silverman // September 25th, 2008 // 10:20 am
Many apologies for the extraordinarily late start today. An unexpected event cropped up this morning that prevented us from pursuing our usual routine. Now, though, we are poised to resume the flow of interesting items. We appreciate your patience and hope that your day goes well…
Merck License Osteoporosis Drug From Japan Tobacco (Yahoo/AP)
Ligand To Buy Pharmacopeia For $70 Million (Yahoo/AP)
Medtronic To Buy CryoCath For $380 Million (Yahoo/Reuters)
PDL BioPharma Names CEO For Spinoff (Yahoo/Associated Press)
Boston Scientific Wins FDA Approval For New Stents (Yahoo/Reuters)
Christopher
Edward,
Very droll…
Anne PME
Ed:
There seems to be a growing number of previously unforseen events these days.
Good to see that you are back so soon. Sometimes, coming back takes longer than anticipated.
Along with other pharmalot fans, best to you, Mrs. Pharmalot, and the little Pharmalots.
Anne